Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Metadata
Title
A novel therapeutic strategy with anti-CD9 antibody in gastric cancers
Publication date
01-09-2009
Published in
Journal of Gastroenterology / Issue 9/2009
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-009-0081-3

Other articles of this Issue 9/2009

Journal of Gastroenterology 9/2009 Go to the issue

Original Article—Liver, Pancreas, and Biliary Tract

Mortality rate of patients with asymptomatic primary biliary cirrhosis diagnosed at age 55 years or older is similar to that of the general population

Original Article—Alimentary Tract

Differential effects of PPARγ activation by the oral antidiabetic agent pioglitazone in Barrett’s carcinoma in vitro and in vivo

Review

Present status and strategy of NSAIDs-induced small bowel injury

Original Article—Alimentary Tract

Use of the lactose-[13C]ureide breath test for diagnosis of small bowel bacterial overgrowth: comparison to the glucose hydrogen breath test

Original Article—Alimentary Tract

Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy

Letter to the editor

Cardiac tamponade originating from gastric cancer

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits